Gliclazid-Mepha Teva MR 30 mg
Gliclazid-Mepha Teva MR 30 mg is a medicine authorised by Swissmedic under authorisation number 65694. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 September 2015 and the authorisation is valid without a time limit. ATC code A10BB09 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65694 |
|---|---|
| Name | Gliclazid-Mepha Teva MR 30 mg |
| Full name | Gliclazid-Mepha Teva MR 30 mg, Retardtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BB09 |
| First authorisation | 17 September 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gliclazid-Mepha Teva MR 30 mg, Retardtabletten | B | 17 September 2015 |
| 2 | Gliclazid-Mepha Teva MR 60 mg, Retardtabletten | B | 17 September 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 30 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 7 | 120 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 8 | 30 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 9 | 90 | Tablette(n) | A10BB09 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gliclazid-Mepha Teva MR 30 mg authorised in Switzerland?
Yes. Gliclazid-Mepha Teva MR 30 mg is authorised by Swissmedic under authorisation number 65694, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gliclazid-Mepha Teva MR 30 mg have?
Gliclazid-Mepha Teva MR 30 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gliclazid-Mepha Teva MR 30 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.